134 related articles for article (PubMed ID: 30838824)
1. Noble Metal Coated Central Venous Catheters Are Not Superior To Uncoated Catheters In Preventing Infectious And Non-Infectious Complications In Immunocompromised Patients.
Iftikhar R; Chaudhry QUN; Satti TM; Mahmood SK; Satti HS; Ghafoor T; Khan MA
J Ayub Med Coll Abbottabad; 2018; 30(Suppl 1)(4):S647-S651. PubMed ID: 30838824
[TBL] [Abstract][Full Text] [Related]
2. Catheter-related infection and thrombosis of the internal jugular vein in hematologic-oncologic patients undergoing chemotherapy: a prospective comparison of silver-coated and uncoated catheters.
Harter C; Salwender HJ; Bach A; Egerer G; Goldschmidt H; Ho AD
Cancer; 2002 Jan; 94(1):245-51. PubMed ID: 11815983
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of central venous catheters coated with a noble metal alloy-A randomized clinical pilot study of coating durability, performance and tolerability.
Björling G; Johansson D; Bergström L; Strekalovsky A; Sanchez J; Frostell C; Kalman S
J Biomed Mater Res B Appl Biomater; 2018 Aug; 106(6):2337-2344. PubMed ID: 29106034
[TBL] [Abstract][Full Text] [Related]
4. Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT).
Gudiol C; Nicolae S; Royo-Cebrecos C; Aguilar-Guisado M; Montero I; Martín-Gandul C; Perayre M; Berbel D; Encuentra M; Arnan M; Cisneros-Herreros JM; Carratalà J
Trials; 2018 May; 19(1):264. PubMed ID: 29720244
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial chlorhexidine/silver sulfadiazine-coated central venous catheters versus those uncoated in patients undergoing allogeneic stem cell transplantation.
Vokurka S; Kabatova-Maxova K; Skardova J; Bystricka E
Support Care Cancer; 2009 Feb; 17(2):145-51. PubMed ID: 18449570
[TBL] [Abstract][Full Text] [Related]
6. The effectiveness of chlorhexidine-silver sulfadiazine impregnated central venous catheters in patients receiving high-dose chemotherapy followed by peripheral stem cell transplantation.
Maaskant JM; De Boer JP; Dalesio O; Holtkamp MJ; Lucas C
Eur J Cancer Care (Engl); 2009 Sep; 18(5):477-82. PubMed ID: 19453696
[TBL] [Abstract][Full Text] [Related]
7. A comparison of infections and complications in central venous catheters in adults with solid tumours.
Coady K; Ali M; Sidloff D; Kenningham RR; Ahmed S
J Vasc Access; 2015; 16(1):38-41. PubMed ID: 25198809
[TBL] [Abstract][Full Text] [Related]
8. Complications of intravascular catheters in ICU: definitions, incidence and severity. A randomized controlled trial comparing usual transparent dressings versus new-generation dressings (the ADVANCED study).
Günther SC; Schwebel C; Hamidfar-Roy R; Bonadona A; Lugosi M; Ara-Somohano C; Minet C; Potton L; Cartier JC; Vésin A; Chautemps M; Styfalova L; Ruckly S; Timsit JF
Intensive Care Med; 2016 Nov; 42(11):1753-1765. PubMed ID: 27734108
[TBL] [Abstract][Full Text] [Related]
9. Chlorhexidine gluconate-coated gel pad dressings for prevention of central venous catheter-related bloodstream infections in patients with hematologic diseases or autologous stem cell transplantation: A registry-based matched-pair analysis.
Teschner D; Berisha M; Panse J; Schmitt T; Fiegle E; Naendrup JH; Neitz J; Schmidt-Hieber M; Hentrich M; Böll B; Schalk E
Eur J Haematol; 2023 Dec; 111(6):914-921. PubMed ID: 37705250
[TBL] [Abstract][Full Text] [Related]
10. Comparison of triple-lumen central venous catheters impregnated with silver nanoparticles (AgTive®) vs conventional catheters in intensive care unit patients.
Antonelli M; De Pascale G; Ranieri VM; Pelaia P; Tufano R; Piazza O; Zangrillo A; Ferrario A; De Gaetano A; Guaglianone E; Donelli G
J Hosp Infect; 2012 Oct; 82(2):101-7. PubMed ID: 22938728
[TBL] [Abstract][Full Text] [Related]
11. Five-Lumen Antibiotic-Impregnated Femoral Central Venous Catheters in Severely Burned Patients: An Investigation of Device Utility and Catheter-Related Bloodstream Infection Rates.
Friedman BC; Mian MA; Mullins RF; Hassan Z; Shaver JR; Johnston KK
J Burn Care Res; 2015; 36(4):493-9. PubMed ID: 25407386
[TBL] [Abstract][Full Text] [Related]
12. One percent chlorhexidine-alcohol for preventing central venous catheter-related infection during intensive chemotherapy for patients with haematologic malignancies.
Ohtake S; Takahashi H; Nakagawa M; Uchino Y; Miura K; Iriyama N; Nakayama T; Hatta Y; Takei M
J Infect Chemother; 2018 Jul; 24(7):544-548. PubMed ID: 29627326
[TBL] [Abstract][Full Text] [Related]
13. Influence of the Insertion Site on Central Venous Catheter-Related Complications in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation.
Heidenreich D; Hansen E; Kreil S; Nolte F; Jawhar M; Hecht de Gutierrez A; Hofmann WK; Klein SA
Biol Blood Marrow Transplant; 2020 Jun; 26(6):1189-1194. PubMed ID: 32084541
[TBL] [Abstract][Full Text] [Related]
14. Short-term dialysis catheter versus central venous catheter infections in ICU patients: a post hoc analysis of individual data of 4 multi-centric randomized trials.
Buetti N; Ruckly S; Lucet JC; Mimoz O; Souweine B; Timsit JF
Intensive Care Med; 2019 Dec; 45(12):1774-1782. PubMed ID: 31624854
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic lock therapy for salvage of tunneled central venous catheters with catheter colonization and catheter-related bloodstream infection.
Zanwar S; Jain P; Gokarn A; Devadas SK; Punatar S; Khurana S; Bonda A; Pruthy R; Bhat V; Qureshi S; Khattry N
Transpl Infect Dis; 2019 Feb; 21(1):e13017. PubMed ID: 30369006
[TBL] [Abstract][Full Text] [Related]
16. Types of indwelling urethral catheters for short-term catheterisation in hospitalised adults.
Lam TB; Omar MI; Fisher E; Gillies K; MacLennan S
Cochrane Database Syst Rev; 2014 Sep; (9):CD004013. PubMed ID: 25248140
[TBL] [Abstract][Full Text] [Related]
17. Prevention of transmission of multidrug-resistant organisms during catheter exchange using antimicrobial catheters.
Jamal MA; Rosenblatt J; Jiang Y; Hachem R; Chaftari AM; Raad II
Antimicrob Agents Chemother; 2014 Sep; 58(9):5291-6. PubMed ID: 24957841
[TBL] [Abstract][Full Text] [Related]
18. Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults.
Lai NM; Chaiyakunapruk N; Lai NA; O'Riordan E; Pau WS; Saint S
Cochrane Database Syst Rev; 2013 Jun; (6):CD007878. PubMed ID: 23740696
[TBL] [Abstract][Full Text] [Related]
19. Reduction of catheter-related infections in neutropenic patients: a prospective controlled randomized trial using a chlorhexidine and silver sulfadiazine-impregnated central venous catheter.
Jaeger K; Zenz S; Jüttner B; Ruschulte H; Kuse E; Heine J; Piepenbrock S; Ganser A; Karthaus M
Ann Hematol; 2005 Apr; 84(4):258-62. PubMed ID: 15549302
[TBL] [Abstract][Full Text] [Related]
20. Scheduled removal of central venous catheters (CVC) to prevent CVC-related bloodstream infections in patients with hematological disease or autologous stem cell transplantation: a registry-based randomized simulation-study.
Panse J; Tölle D; Fiegle E; Naendrup JH; Schmidt-Hieber M; Böll B; Hentrich M; Teschner D; Schalk E
Ann Hematol; 2022 Oct; 101(10):2317-2324. PubMed ID: 35978182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
